Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.40 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | TOP2A | P11388 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10666704 | 0.96 | DGKA (0.45) | DGKAALDH1A1HPGDADRA2AADRA1A | |
| SCHEMBL5014579 | 0.92 | LMNA (0.54) | DGKAALDH1A1HPGDADRA2AADRA1A | |
| SCHEMBL17371400 | 0.91 | DGKA (0.45) | DGKAALDH1A1HPGDADRA2AADRA1A | |
| SCHEMBL6616344 | 0.90 | DGKA (0.41) | DGKAALDH1A1HPGDADRA2AADRA1A | |
| SCHEMBL28707585 | 0.89 | NAAA (0.58) | DGKADNM1PLA2G4BHTR2CNAAA | |
| SCHEMBL112324 | 0.87 | DGKA (0.55) | DGKAALDH1A1HPGDMAPTDNM1 | |
| SCHEMBL283830 | 0.86 | DGKA (0.48) | DGKAALDH1A1ADRA2AADRA1AMAPT | |
| SCHEMBL29986668 | 0.85 | NAAA (0.59) | DGKADNM1PLA2G4BHTR2CNAAA | |
| SCHEMBL15222131 | 0.84 | DGKA (0.47) | DGKAALDH1A1ADRA2AADRA1AMAPT | |
| SCHEMBL16865882 | 0.84 | DGKA (0.37) | DGKAALDH1A1HPGDADRA2AADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102802605-A | Stable lipid formulations of apoptosis promoters | ABBOTT LAB | 2012-11-28 | — | — | CN | claimed |
| EP-2424499-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | Abbott Laboratories (US) | 2012-03-07 | — | — | EP | claimed |
| WO-2010127193-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBOTT LABORATORIES (US) | 2010-11-04 | — | — | WO | claimed |
| US-20100278905-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBVIE INC. | 2010-11-04 | — | — | US | claimed |
| CN-115521435-A | Resin, curable resin composition, cured product, insulating material, and resist member | DIC株式会社 | 2022-12-27 | — | — | CN | disclosed |
| US-20220326613-A1 | PHOTOSENSITIVE TRANSFER MATERIAL AND METHOD OF PRODUCING THE SAME, METHOD OF PRODUCING PATTERNED METAL CONDUCTIVE MATERIAL, FILM, TOUCH PANEL, METHOD OF SUPPRESSING DETERIORATION, AND LAMINATE | FUJIFILM CORPORATION (JP) | 2022-10-13 | — | — | US | disclosed |
| WO-2020040249-A1 | HEAT-RESISTANT RELEASE AGENT COMPOSITION | 株式会社ネオス | 2020-02-27 | — | — | WO | disclosed |
| US-9309481-B2 | Lubricant composition | IDEMITSU KOSAN CO., LTD. (JP) | 2016-04-12 | — | — | US | disclosed |
| CN-102802605-B | Stable lipid formulations of apoptosis promoters | ABBVIE (US) | 2015-08-12 | — | — | CN | disclosed |
| US-8927009-B2 | ABT-263 capsule | ABBVIE INC. (US) | 2015-01-06 | — | — | US | disclosed |
| US-8728516-B2 | Stabilized lipid formulation of apoptosis promoter | ABBVIE INC. (US) | 2014-05-20 | — | — | US | disclosed |
| US-8513243-B2 | ABT-263 crystalline forms | ABBVIE INC. (US) | 2013-08-20 | — | — | US | disclosed |
| WO-2010127198-A1 | FORMULATION FOR ORAL ADMINISTRATION OF APOPTOSIS PROMOTER | ABBOTT LABORATORIES (US) | 2010-11-04 | — | — | WO | disclosed |
| WO-2010127193-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBOTT LABORATORIES (US) | 2010-11-04 | — | — | WO | disclosed |
| US-20100278905-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBVIE INC. | 2010-11-04 | — | — | US | disclosed |
| EP-1947725-A2 | Polymer electrolyte composition and fuel cell | Sumitomo Chemical Company, Limited (JP) | 2008-07-23 | — | — | EP | disclosed |
| EP-1289041-B1 | Polymer electrolyte composition and fuel cell | SUMITOMO CHEMICAL CO (JP) | 2008-03-12 | — | — | EP | disclosed |
| US-20060257706-A1 | POLYMER ELECTROLYTE COMPOSITION AND FUEL CELL | HIDAKA YASUAKI | 2006-11-16 | — | — | US | disclosed |
| US-20030113605-A1 | Polymer electrolyte composition and fuel cell | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-06-19 | — | — | US | disclosed |
| EP-1289041-A2 | Polymer electrolyte composition and fuel cell | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100278905-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | BCL2, BAX, BCOR | DGKA 2084/4885ALDH1A1 3985/4885HPGD 806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.